Private Advisor Group, LLC

Position in IBRX — ImmunityBio, Inc.

CIK 1567755 MORRISTOWN, NJ

Position in IBRX

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$1,452,927

-$11,191,497 QoQ

Shares Held

165,954

-89.9% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#85

of 404 holders

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Private Advisor Group, LLC holds $44,247,243 across 48 Biotechnology names. IBRX ranks #7 (3.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	18,557	$11,571,031
2	CRSP	CRISPR Therapeutics AG	111,129	$6,060,975
3	CRMD	CorMedix Inc.	415,406	$3,260,937
4	ARWR	Arrowhead Pharmaceuticals, Inc.	30,352	$2,473,991
5	TLX	Telix Pharmaceuticals Ltd	197,250	$2,274,292
6	VRTX	Vertex Pharmaceuticals Inc / Ma	4,130	$2,051,494
7	IBRX	ImmunityBio, Inc. This page	165,954	$1,452,927
8	AVXL	Anavex Life Sciences Corp.	504,000	$1,305,360

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,452,927	165,954	-89.9%	Shares	Sole	2026-07-27
2026-03-31	$12,644,424	1,648,556	+923.5%	Shares	Sole	2026-04-27
2025-12-31	$318,926	161,074	+1153.3%	Shares	Sole	2026-02-17
2025-09-30	$31,615	12,852	-1.6%	Shares	Sole	2025-11-13
2025-06-30	$34,465	13,055	+1.6%	Shares	Sole	2025-08-11
2025-03-31	$38,684	12,852	-4.4%	Shares	Sole	2025-05-05
2024-12-31	$34,432	13,450	-75.4%	Shares	Sole	2025-02-03
2024-09-30	$203,733	54,767	-37.0%	Shares	Sole	2024-10-22
2024-06-30	$549,252	86,907	+727.7%	Shares	Sole	2024-08-05
2024-03-31	$56,385	10,500	0.0%	Shares	Sole	2024-04-30
2023-12-31	$52,710	10,500	—	Shares	Sole	2024-02-06
No filing history on record for this holder in this stock.